Document Detail


A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
MedLine Citation:
PMID:  16427545     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Epsilon-aminocaproic acid is a plasmin inhibitor that potentially reduces perioperative bleeding when administered prophylactically to cardiac surgery patients. To evaluate the efficacy of epsilon-aminocaproic acid, a prospective placebo-controlled trial was conducted in patients undergoing primary coronary artery bypass grafting surgery. STUDY DESIGN: One hundred patients were randomly assigned to receive either epsilon-aminocaproic acid (100 mg/kg before skin incision followed by 1 g/hour continuous infusion until chest closure, 10 g in cardiopulmonary bypass circuit) or placebo, and the efficacy of epsilon-aminocaproic acid was evaluated by the reduction in postoperative thoracic-drainage volume and in donor-blood transfusion up to postoperative day 12. RESULTS: Postoperative thoracic-drainage volume was significantly lower in the epsilon-aminocaproic acid group compared with the placebo group (epsilon-aminocaproic acid, 649 +/- 261 mL; versus placebo, 940 +/- 626 mL; p=0.003). There were no significant differences between the epsilon-aminocaproic acid and placebo groups in the percentage of patients requiring donor red blood cell transfusions (epsilon-aminocaproic acid, 24%; versus placebo, 18%; p=0.62) or in the number of units of donor red blood cells transfused (epsilon-aminocaproic acid, 2.2 +/- 0.8 U; versus placebo, 1.9 +/- 0.8 U; p=0.29). Epsilon-aminocaproic acid did not reduce the risk of donor red blood cell transfusions compared with placebo (odds ratio: 1.2, 95% confidence interval; 0.4 to 3.2, p=0.63). CONCLUSIONS: Prophylactic administration of epsilon-aminocaproic acid reduces postoperative thoracic-drainage volume by 30%, but it may not be potent enough to reduce the requirement and the risk for donor blood transfusion in cardiac surgery patients. This information is useful for deciding on a therapy for hemostasis in cardiac surgery.
Authors:
Mutsuhito Kikura; Jerrold H Levy; Kenichi A Tanaka; James G Ramsay
Related Documents :
22605055 - A dermatitis secondary to amino-acid deficiency in treated maple syrup urine disease-re...
21826775 - Papain-catalyzed peptide bond formation: enzyme-specific activation with guanidinopheny...
17066785 - Acute contact toxicity of oxalic acid to varroa destructor (acari: varroidae) and their...
6424275 - Pharmacokinetics of enteric-coated valproic acid.
21258175 - The effect of pantothenic acid deficiency on keratinocyte proliferation and the synthes...
22605055 - A dermatitis secondary to amino-acid deficiency in treated maple syrup urine disease-re...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2005-12-19
Journal Detail:
Title:  Journal of the American College of Surgeons     Volume:  202     ISSN:  1072-7515     ISO Abbreviation:  J. Am. Coll. Surg.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-23     Completed Date:  2006-03-10     Revised Date:  2006-08-07    
Medline Journal Info:
Nlm Unique ID:  9431305     Medline TA:  J Am Coll Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  216-22; quiz A44-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology, Emory University School of Medicine, Emory University Hospital, The Emory Clinic, Atlanta, GA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
6-Aminocaproic Acid / therapeutic use*
Adult
Aged
Antifibrinolytic Agents / therapeutic use*
Blood Loss, Surgical / prevention & control*
Blood Transfusion / statistics & numerical data
Coronary Artery Bypass*
Double-Blind Method
Female
Humans
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Antifibrinolytic Agents; 60-32-2/6-Aminocaproic Acid
Comments/Corrections
Comment In:
Evid Based Cardiovasc Med. 2006 Jun;10(2):149-51   [PMID:  16753544 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship between American College of Surgeons trauma center designation and mortality in patient...
Next Document:  Surgical outcomes in patients with T4 gastric carcinoma.